Skip to main content

Advertisement

SpringerLink
Log in

Association between ERCC1 C8092A and ERCC2 K751Q polymorphisms and risk of adult glioma: a meta-analysis

  • Research Article
  • Published:
Tumor Biology

Abstract

While the ERCC1 C8092A and ERCC2 K751Q polymorphisms have received much attention for their potential associations with adult glioma risk, inferences from such studies are hindered by their limited statistical power and conflicting results. The aim of this meta-analysis is to provide a relatively comprehensive account of the association between these two polymorphisms and adult glioma risk. A literature search for eligible studies published before September 1, 2013 was conducted in PubMed, Embase, Web of Science, Cochrane Library, and CNKI databases. Pooled odds ratios (ORs) with their corresponding 95 % confidence intervals (95 % CIs) were used to evaluate the strength of the association under a fixed or random effect model according to heterogeneity test results. All analyses were performed using STATA software, version 12.0. Ten case–control studies were included in this meta-analysis, with a total of 5,843 adult glioma patients and 8,139 healthy controls. For ERCC1 C8092A (dbSNP: rs3212986, C>A), the combined results show that carriers of the AA genotype may be associated with a higher risk of adult glioma than carriers of the CA and CC genotypes. Stratified analyses show that the magnitude of the effect was especially significant among Asians, indicating ethnicity differences in adult glioma susceptibility. For ERCC2 K751Q (dbSNP: rs13181, A>C), the pooled ORs were not significant in the overall population, although all of the ORs were greater than 1. However, Asians seem to be significantly more susceptible to adult glioma than Caucasians. The results of this meta-analysis indicate that the AA genotype of ERCC1 C8092A may be associated with a higher risk of adult glioma than the CA and CC genotypes and that the risk allele of ERCC2 K751Q confers a significant susceptibility to adult glioma, especially in Asian populations. These polymorphisms may be used along with other genetic markers to identify individuals at high risk for adult glioma.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Schwartzbaum JA, Fisher JL, Aldape KD, Wrensch M. Epidemiology and molecular pathology of glioma. Nat Clin Pract Neurol. 2006;2:494–503. quiz 1 p following 16.

    Article  PubMed  Google Scholar 

  2. Dolecek TA, Propp JM, Stroup NE, Kruchko C. CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the united states in 2005–2009. Neuro Oncol. 2012;14 Suppl 5:v1–v49.

    Article  PubMed Central  PubMed  Google Scholar 

  3. Bellail AC, Hunter SB, Brat DJ, Tan C, Van Meir EG. Microregional extracellular matrix heterogeneity in brain modulates glioma cell invasion. Int J Biochem Cell Biol. 2004;36:1046–69.

    Article  CAS  PubMed  Google Scholar 

  4. Plascak JJ, Fisher JL. Area-based socioeconomic position and adult glioma: a hierarchical analysis of surveillance epidemiology and end results data. PLoS One. 2013;8:e60910.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  5. Perera FP. Environment and cancer: who are susceptible? Science. 1997;278:1068–73.

    Article  CAS  PubMed  Google Scholar 

  6. Burcham PC. Internal hazards: baseline DNA damage by endogenous products of normal metabolism. Mutat Res. 1999;443:11–36.

    Article  CAS  PubMed  Google Scholar 

  7. Liu BH, Yu FY, Wu TS, Li SY, Su MC, et al. Evaluation of genotoxic risk and oxidative DNA damage in mammalian cells exposed to mycotoxins, patulin and citrinin. Toxicol Appl Pharmacol. 2003;191:255–63.

    Article  CAS  PubMed  Google Scholar 

  8. Little JB. Genomic instability and radiation. J Radiol Prot. 2003;23:173–81.

    Article  CAS  PubMed  Google Scholar 

  9. Ames BN. DNA damage from micronutrient deficiencies is likely to be a major cause of cancer. Mutat Res. 2001;475:7–20.

    Article  CAS  PubMed  Google Scholar 

  10. Helleday T, Petermann E, Lundin C, Hodgson B, Sharma RA. DNA repair pathways as targets for cancer therapy. Nat Rev Cancer. 2008;8:193–204.

    Article  CAS  PubMed  Google Scholar 

  11. Goode EL, Ulrich CM, Potter JD. Polymorphisms in DNA repair genes and associations with cancer risk. Cancer Epidemiol Biomarkers Prev. 2002;11:1513–30.

    CAS  PubMed  Google Scholar 

  12. Wood RD, Mitchell M, Lindahl T. Human DNA repair genes, 2005. Mutat Res. 2005;577:275–83.

    Article  CAS  PubMed  Google Scholar 

  13. Smith JS, Tachibana I, Pohl U, Lee HK, Thanarajasingam U, et al. A transcript map of the chromosome 19q-arm glioma tumor suppressor region. Genomics. 2000;64:44–50.

    Article  CAS  PubMed  Google Scholar 

  14. Garcia-Closas M, Malats N, Real FX, Welch R, Kogevinas M, et al. Genetic variation in the nucleotide excision repair pathway and bladder cancer risk. Cancer Epidemiol Biomarkers Prev. 2006;15:536–42.

    Article  CAS  PubMed  Google Scholar 

  15. Munafo MR, Flint J. Meta-analysis of genetic association studies. Trends Genet. 2004;20:439–44.

    Article  CAS  PubMed  Google Scholar 

  16. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009;339:b2535.

    Article  PubMed Central  PubMed  Google Scholar 

  17. Little J, Higgins JP, Ioannidis JP, Moher D, Gagnon F, et al. Strengthening the Reporting of Genetic Association studies (STREGA): an extension of the STROBE statement. Hum Genet. 2009;125:131–51.

    Article  PubMed  Google Scholar 

  18. Stang A. Critical evaluation of the Newcastle–Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25:603–5.

    Article  PubMed  Google Scholar 

  19. Jackson D, White IR, Riley RD. Quantifying the impact of between-study heterogeneity in multivariate meta-analyses. Stat Med. 2012;31:3805–20.

    Article  PubMed Central  PubMed  Google Scholar 

  20. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21:1539–58.

    Article  PubMed  Google Scholar 

  21. Peters JL, Sutton AJ, Jones DR, Abrams KR, Rushton L. Comparison of two methods to detect publication bias in meta-analysis. JAMA. 2006;295:676–80.

    Article  CAS  PubMed  Google Scholar 

  22. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629–34.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  23. Chen P, Wiencke J, Aldape K, Kesler-Diaz A, Miike R, et al. Association of an ercc1 polymorphism with adult-onset glioma. Cancer Epidemiol Biomarkers Prev. 2000;9:843–7.

    CAS  PubMed  Google Scholar 

  24. Wrensch M, Kelsey KT, Liu M, Miike R, Moghadassi M, et al. ERCC1 and ERCC2 polymorphisms and adult glioma. Neuro Oncol. 2005;7:495–507.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  25. Liu Y, Scheurer ME, El-Zein R, Cao Y, Do KA, et al. Association and interactions between DNA repair gene polymorphisms and adult glioma. Cancer Epidemiol Biomarkers Prev. 2009;18:204–14.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  26. McKean-Cowdin R, Barnholtz-Sloan J, Inskip PD, Ruder AM, Butler M, et al. Associations between polymorphisms in DNA repair genes and glioblastoma. Cancer Epidemiol Biomarkers Prev. 2009;18:1118–26.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  27. Chen DQ, Yao DX, Zhao HY, Yang SJ. DNA repair gene ERCC1 and XPD polymorphisms predict glioma susceptibility and prognosis. Asian Pac J Cancer Prev. 2012;13:2791–4.

    Article  PubMed  Google Scholar 

  28. Zhang N, Lin LY, Zhu LL, Wu F, Wen H, et al. ERCC1 polymorphisms and risk of adult glioma in a Chinese population: a hospital-based case–control study. Cancer Invest. 2012;30:199–202.

    Article  PubMed  Google Scholar 

  29. Pan WR, Li G, Guan JH. Polymorphisms in DNA repair genes and susceptibility to glioma in a Chinese population. Int J Mol Sci. 2013;14:3314–24.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  30. Caggana M, Kilgallen J, Conroy JM, Wiencke JK, Kelsey KT, et al. Associations between ERCC2 polymorphisms and gliomas. Cancer Epidemiol Biomarkers Prev. 2001;10:355–60.

    CAS  PubMed  Google Scholar 

  31. Rajaraman P, Hutchinson A, Wichner S, Black PM, Fine HA, et al. DNA repair gene polymorphisms and risk of adult meningioma, glioma, and acoustic neuroma. Neuro Oncol. 2010;12:37–48.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  32. Luo KQ, Mu SQ, Wu ZX, Shi YN, Peng JC. Polymorphisms in DNA repair genes and risk of glioma and meningioma. Asian Pac J Cancer Prev. 2013;14:449–52.

    Article  PubMed  Google Scholar 

  33. Vanan I, Dong Z, Tosti E, Warshaw G, Symons M, et al. Role of a DNA damage checkpoint pathway in ionizing radiation-induced glioblastoma cell migration and invasion. Cell Mol Neurobiol. 2012;32:1199–208.

    Article  CAS  PubMed  Google Scholar 

  34. Mahaney BL, Meek K, Lees-Miller SP. Repair of ionizing radiation-induced DNA double-strand breaks by non-homologous end-joining. Biochem J. 2009;417:639–50.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  35. Hoeijmakers JH. DNA damage, aging, and cancer. N Engl J Med. 2009;361:1475–85.

    Article  CAS  PubMed  Google Scholar 

  36. Shete S, Hosking FJ, Robertson LB, Dobbins SE, Sanson M, et al. Genome-wide association study identifies five susceptibility loci for glioma. Nat Genet. 2009;41:899–904.

    Article  CAS  PubMed  Google Scholar 

  37. Rajaraman P, Melin BS, Wang Z, McKean-Cowdin R, Michaud DS, et al. Genome-wide association study of glioma and meta-analysis. Hum Genet. 2012;131:1877–88.

    Article  PubMed Central  PubMed  Google Scholar 

  38. Lai R, Crevier L, Thabane L. Genetic polymorphisms of glutathione S-transferases and the risk of adult brain tumors: a meta-analysis. Cancer Epidemiol Biomarkers Prev. 2005;14:1784–90.

    Article  CAS  PubMed  Google Scholar 

  39. Tan D, Xu J, Li Y, Lai R. Association between +61g polymorphism of the EGF gene and glioma risk in different ethnicities: a meta-analysis. Tohoku J Exp Med. 2010;222:229–35.

    Article  CAS  PubMed  Google Scholar 

  40. Jacobs DI, Bracken MB. Association between XRCC1 polymorphism 399 g→a and glioma among Caucasians: a systematic review and meta-analysis. BMC Med Genet. 2012;13:97.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  41. He F, Xia Y, Liu H, Li J, Wang C. P53 codon 72 arg/pro polymorphism and glioma risk: an updated meta-analysis. Tumour Biol. 2013;34:3121–30.

    Article  CAS  PubMed  Google Scholar 

  42. Lu Q, Dai D, Zhao W, Wang L, Yue Z, et al. Association between mthfr 677c>t polymorphism and risk of gliomas: evidence from a meta-analysis. Tumour Biol. 2013;34:2801–7.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgment

This work was supported by the grants from Clinical Application of Molecular Diagnostic Techniques in Personalized Brain Tumor Therapy (W2012FZ009), Development Center for Medical Science and Technollgy, Ministry of Health ,P.R.China.

Conflicts of interest

None

Author information

Authors and Affiliations

  1. Department of Neurosurgery, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, No.1 Shuaifuyuan, Beijing, 100730, China

    Zhiqin Xu, Wenbin Ma, Lu Gao & Bing Xing

Authors
  1. Zhiqin Xu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Wenbin Ma
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Lu Gao
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Bing Xing
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Bing Xing.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Xu, Z., Ma, W., Gao, L. et al. Association between ERCC1 C8092A and ERCC2 K751Q polymorphisms and risk of adult glioma: a meta-analysis. Tumor Biol. 35, 3211–3221 (2014). https://doi.org/10.1007/s13277-013-1420-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13277-013-1420-9

Keywords

Search

Navigation